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Summary 
Cytotoxic T  lymphocytes (CTL) can recognize antigenic peptides bound in a groove formed 
by the od and ol2 domains of the heterodimeric major histocompatibility  complex class I molecule. 
Proper assembly, transport, and stability of functional class I molecules is thought to require 
32 microglobulin (32m),  the light chain of the class I  heterodimer. We show here that the 
requirement for 32m is not absolute.  32m- cells can be stained by the D b oO domain-specific 
B22-249.1 monoclonal antibody, which detects a conformation-dependent  epitope. Furthermore, 
32m- Con A blast target cells can be lysed by alloreactive CTL, even in serum-free conditions. 
Contrary to previous reports, the expression  of low levels of conformed D b heavy (H) chains 
is a property of both normal and transformed 32m- cells. Finally, we present evidence that a 
subset of properly conformed H chains, free of 3zm, may have almost equal representation on 
32m +  and 32m-  cells. 
M 
HC class I molecules are composed of a 45-kD poly- 
morphic H  chain noncovalently associated  with 32 
microglobulin (~2m) 1. Previous studies have suggested that 
32m is critical for the normal function of class I molecules. 
In mutant cells that are unable to synthesize 32m, most class 
I H  chains accumulate intraceUularly  and are degraded (1, 
2). Some class I H chains, such as D b, reach the cell surface 
in 32m-deficient cell lines such as the 32m-  R1E cell line 
(C58 origin, H-2k), which had been transected with the D b 
gene (R1E/D b) (1). Cell surface expression of D b in 32m- 
tumor cells could be detected with the 28-14-8s mAb, that 
reacts with the c~3 domain of the D b molecule. However, 
the levels of cell surface D b expression were reduced in the 
32m-  cells compared with the same cells supertransfected 
with 32m (R1E/Db/32m). More importantly, the peptide- 
binding domains of D b molecules on the surface of R1E/D b 
cells apparently assume an altered conformation, as shown 
by their failure to react with mAb specific for the cd (e.g., 
B22-249.1)  or or2 domains of D b (1, 3).  Furthermore, al- 
loreactive or antigen-speeific/class I-restricted cytotoxic T cells 
specific for D b failed to react with R1E/D b cells, suggesting 
an important role for 32m in generating class I complexes 
visible to the TCR. These experiments suggested that 32m 
plays an obligatory role in inducing and/or maintaining a 
functional conformation of class I molecules. 
We have examined cell surface class I expression on cells 
from mice homozygous for a targeted mutation in their 32m 
1 Abbreuiation used in this paper: 32m, 3z microglobulin. 
gene. We previously reported (4) preliminary findings that 
cells from these mice fail to synthesize 32m, and have essen- 
tially no serologically detectable levels of K b or Qa2 class I 
molecules on their surface. However, low levels (about 1/20th 
the level found on 32m + cells) of D b molecules were de- 
tected  on  freshly  isolated  T  cells  from  32m-  mice  by 
staining with Db-specific mAbs 28-14-8s, B22-249.1,  and 
27-11-13s. Furthermore, 32m- Con A blasts could be lysed, 
albeit  inefficiently,  by  populations  of alloreactive,  H-2  b- 
specific CTL. Our findings that 32m- cells can be stained 
by al-specific B22-249 mAb, and that 3~m-  Con A blast 
target cells can be lysed by alloreactive CTL, contrast with 
previous reports that 32m- RIE/D  b tumor cells are neither 
stained by B22-249.1 mAb, nor are lysed by alloreactive CTL. 
Our earlier studies were performed in serum-containing 
medium. Serum contains free 32m that could potentially 
bind to free class I H chains, resulting in a functional confor- 
mation of the molecules (5). Furthermore, 32m shed from 
the CTL used in the functional experiments might have trans- 
ferred onto the target cells. In the present paper, we provide 
direct evidence that functional, conformed free dass I H chains 
exist on the surface of 32m-  cells in the absence of 32m. 
The implications of these findings for the normal function 
of class I molecules are discussed. 
Materials and Methods 
Mice.  All ~zm- strains (4) were bred at the Life Science Ad- 
dition Animal Facility (University of California, Berkeley) or the 
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nology (Cambridge, MA). All other strains were purchased from 
The Jackson Laboratory (Bar Harbor,  ME). 
Tumor Cells.  R1E/D  b and R.1E/D~//~2m (6) were a generous 
gift from M. Zuffiga (University  of California,  Santa Cruz). 
Cell Culture Media.  Media  containing  bovine  /32m: RPMI 
1640, 5% FCS, 5 #g/ml gentamicin, 100 U/ml penicillin, 100 pg/ml 
streptomycin, 20 mM Hepes, and 50 pM 2-ME (RP-5). B2m free 
media: AIM-V (Gibco Laboratories, Grand Island, NY), and 50 
/~M 2-ME. 
Antibodies.  Allophycocyanin-conjugated streptavidin was ob- 
tained  from  Molecular  Probes  (Eugene,  OR).  Fluorescein- 
conjugated goat anti-mouse Ig (cat. no. 1010-02)  was obtained from 
Southern  Biotechnology  Associates (Birmingham,  AL).  Sheep 
anti-fluorescein-conjugated magnetic beads (cat. no. 4310D) were 
obtained from Advanced Magnetics (Cambridge, MA). Anti-CD8 
(AD4115]), anti-CD4  (ILL174), anti-NKl.1  (PK136), and anti-K k 
(16-1-2n) can be obtained from the American Type Culture Collec- 
tion (Rockville, MD). Anti-D b c~1 (B22-249.1) was a gift from 
P. Walden (Max Planck Institute,  Tiibingen,  Germany) and was 
biotinylated using standard methods. Anti-Thy-l.2 (J1J) was a gift 
from J. Sprent (The Scripps Research Institute,  La Jolla,  CA). 
Radiation Bone Marrow Chimeras.  Bone marrow was prepared 
from female fl2m-  H-2  k homozygous  mice (5 mo-old) resulting 
from the intercross of the 4th backcross generation of B10.BR x 
(B6 x  129)F1, and was depleted of T cells by treatment with anti- 
Thyl.2 (JIJ) plus complement. Ten million T-depleted marrow cells 
were injected into female B10.BR mice (3-5 too-old) irradiated (980 
tad from a 137Cs source) '~2 h earlier. To prevent rejection of the 
class I-deficient marrow  grafts by NK cells, all recipients were 
depleted of NKI.1 + cells by intraperitoneal injection with 200/xg 
PK136 1 d earlier (7). Spleen cells were harvested for analysis 12 wk 
later. 
Immunofluorescent Staining Analysis.  Lymph node suspensions 
from individual mice or tumor cells were stained at 106 cells/25 
pl  for  20  rain  at  4~  in  either  PBS, 5%  FCS,  0.2%  NaN3 
(medium  containing  B2m), or  PBS, 14 /~g/ml  ~-galactosidase 
(Sigma Chemical Co., St. Louis, MO), and 0.2% NaN3 (/32m-free 
staining media). Between stains, cells were washed two times. After 
the final wash, cells were fixed in 1% paraformaldehyde and stored, 
foil wrapped,  at 4~  until analysis. Analysis was performed on a 
FACStar +|  flow cytometer. Typically, 20,000 cells per sample were 
analyzed. 
Cytolysis Analysis.  Primary MLC were established essentially 
as described (8). Briefly, 25  x  106 responder splenocytes and 25 
x  106 stimulator  splenocytes (receiving 3,000 rad from a 137Cs 
source) were cultured together in 20 ml of RP-5 in upright T-25 
flasks (Coming Glass Works, Corning,  NY) for 5 d and then har- 
vested for cytolysis assay. Cells harvested on day 9 or 10 from 1  ~ 
MLC  were  reestablished  in  2 ~  MLC  (2-3  x  106  responder 
cells/culture) with fresh stimulator  cells (25  x  106 cells/culture) 
and cultured for 4 d before harvesting for assay. The cytolysis assay 
was performed essentially as described (8) either in RP-5 or AIM-V, 
as indicated. For target cell preparation, splenocytes were cultured 
for 2 or 3 d in 24-well plates (Falcon Plastics, Lincoln Park, NJ) 
at 2  x  106 cells/ml with 2 pg/ml Con A (when culturing  in 
RP-5),  and 0.33 pg/ml Con A (when culturing  in AIM-V). 
Immunomagnetic Depletion of B Cells.  B2m- spleen cells were 
stained with affinity-purified, fluorescein-conjugated,  goat anti- 
mouse Ig antibody in ~zm-free staining media for 20 min at 4~ 
washed  two  times,  then  treated  with  sheep  anti-fluorescein- 
conjugated  magnetic beads (Advanced Magnetics) for 30 min at 
4~  with gentle  rocking.  Ig + (and hence, magnetic)  cells were 
removed by exposing the cell suspension for 15 min at room tem- 
perature  to a strong  magnetic  field using  a Biomag device (Ad- 
vanced Magnetics). Nonimmob'dized cells were recovered and passed 
a second time through the Biomag device to remove any remaining 
Ig § cells. Recovered cells were washed into AIM-V medium be- 
fore the cytolysis assay. 
Antibody Plus Complement Depletion.  CTL populations  were 
resuspended at 20  x  106 cells/ml in RP-5, and the optimal dilu- 
tion of mAb and a mixture of rabbit and guinea pig complement. 
After incubation  at 37~  for 40 min, viable cells were recovered 
by passage over a ficoll gradient and washed into the appropriate 
media. 
Results 
Polyclonal CTL populations specific for H-2  b were gener- 
ated in MLC, in which BALB/c (H-2  a) or B10.BR (H-2  k) 
spleen  cells  were  stimulated  with  B6  (H-2  b)  stimulator 
spleen cells. In most cases, the CTL were restimulated with 
B6 spleen cells before assaying their activity. The CTL were 
tested for their  capacity to lyse Con A  blast targets  from 
H-2b-type ~2m-  or ~2m + mice (Fig.  1). Corroborating our 
earlier study, B2m-  target cells were lysed by the CTL,  al- 
though substantially less efficiently than were ~/2m + target 
cells.  To  achieve  equivalent  lysis  of ~2m-  target  cells,  50 
times more CTL from primary MLC were usually required 
than for lysis of/3zm + target cells (Fig.  1 A). CTL from sec- 
ondary MLC appeared capable of more efficient relative lysis 
of B2m-  target  cells,  since  only  10-20  times  more  CTL 
from  secondary MLC  were  typically required  for lysis  of 
B2m-  target  cells than  for lysis  of B2m + target  cells  (Fig. 
1 B). There was no significant lysis of syngeneic (BALB/c 
or B10.BK)/32m + target cells by any of these CTL, demon- 
strating  their  specificity. 
Previous studies have shown that bovine B2m, present in 
FCS, can associate  with  class I  H  chains  on cells  cultured 
in serum-containing  medium (5).  It was therefore possible 
that  lysis of ~2m-  cells by CTL depended on the binding 
of serum ~2m to free class I H chains on the surface of/32m- 
cells. To test this possibility, we compared experiments per- 
formed in FCS-containing medium with those performed in 
AIM-V serum-free medium.  The two media were used for 
generating target cell blasts and for the cytolysis assay. Be- 
cause AIM-V medium failed to support the generation of high 
levels of CTL activity in MLC, the CTL were generated in 
FCS-containing  medium,  and were washed extensively in 
AIM-V medium before the cytolysis assay. As shown in Fig. 
1, A  and B, a similar extent of lysis of ~2m-  target cells was 
observed in FCS-containing medium as in AIM-V serum-free 
medium, indicating that serum ~2m is not necessary for lysis 
of/32m-  cells by CTL. 
The lysis of ~2m-  target cells is not mediated by MHC 
class II (MHC-II)-specific CTL, because T-blast target cells, 
which do not express MHC-II in the mouse, were employed 
for all of these experiments. To rule out the possibility that 
contaminating  B cell blasts in the Con A blast preparation 
are responsible for the observed lysis, we employed as target 
cells B2m- Con A blasts that had been depleted of class II + 
B cells before culture, by immunomagnetic separation with 
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Figure 1.  Lysis  of/~2m- target cells by allospecific  CTL in serum-free 
medium. (A) Anti-H-2  b effector cells from a primary BALB/c anti-B6 
MLC tested on Con A blast target cells. (B) Anti-H-2  b effector  cells from 
a secondary  B10.BR anti-B6 MLC tested  on Con A blast target cells. Target 
cells were prepared by culture on medium containing FCS or in serum- 
free AIM-V medium. Assays  were performed in AIM-V medium. Target 
cells were: (I) H-2  b/~zm  +  , FCS; (O) H-2  b/~2m +  , AIM-V; (I-q) H-2  b 
3zm-, FCS; (O) H-2  b B2m-, AIM-V; (A) H-2b 32m-, AIM-V, B cell- 
depleted; (A) H-2  a 32m + FCS; (V) H-2  ~ 32m +, FCS. The H-2  b/32m + 
and B2m- targets were from (B6 x  129)F2-4 animals, the H-2  d targets 
were from BALB/c  mice, and the H-2  k targets were from B10.BR mice. 
anti-Ig coated magnetic beads. These target cells were lysed 
as efficiently as target cells from which B cells had not been 
specifically depleted (Fig.  1 B). 
The effector cells that lyse H-2  b, 32m-  target cells were 
typed for expression of cell surface markers by treating the 
effector cell population with specific mAb and complement 
before the cytolysis assay. Treatment of the population with 
anti-CD8 mAb plus complement strongly reduced lysis of 
B2m- cells, whereas treatment with anti-CD4 plus comple- 
ment or anti-NKl.1 plus complement had no effect. There- 
fore, lysis of 32m-  cells by these cytolytic cells is mediated 
by CTL of the conventional CDS+CD4-NKI.1 -  pheno- 
type (Fig.  2).  Although our previous results indicate that 
NKI.I+CDS-  NK cells can also lyse 3zm- target cells (9), 
A 
80" 
tO  " 
~0. r"-  >- 
.J 
o 
40" 
g  ￿9 
I:1_  20" 
cO  . 
g~ 
O" 
10  100 
B 
80 
40 
0 
IO 
EFFECTORITARGET  RATIO 
Figure 2.  Lysis  of/Jzm- targets is mediated by CD8+CD4-NKI.1 - 
cells. Anti-H-2  b effector cells from B10.BR anti-B6 MLC were treated 
with antibody and complement, or complement alone, before assay on 
Bzm- or Bzm  + targets, as indicated. (I, I-q, A) C alone; (O) anti-CD8 
plus C; (A) anti-NKl.l in pand A, anti-CD4 plus C in panel B. (rq, 
O, A) H-2  b/~2m- targets; (I) H-2  b/3zm + targets; and (A) H-2  k ~Szrn  + 
targets. The H-2  b 3zm + and 32m-  targets were from (B6  x  129)F2--4 
animals, and the H-2  k targets were from B10.BR mice. 
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Figure 3.  Lysis  of Bzm- target cells by polyclonal allospecitic CTL 
specific for D  b region molecules, or K  b A  b region molecules. CTL specific 
for D b region molecules were raised in secondary  B10.A(18R) anti-B6 
MLC (A). CTL specific for K  b and A  b region molecules were raised in 
secondary  B10.A(4R) anti-B6 MLC. The CTL were tested for lysis  of the 
indicated target cells. (I) H-2  b/~2m  + targets; (f-q) H-2b 32m-  targets; 
(A) B10.A(18R) targets; and (A) B10.A(4R) targets. 
the conditions of the MLC apparently do not support the 
growth or activation of NK cells. 
To identify the MHC molecule(s) responsible for lysis of 
/32m-  target cells, we used spleen cells from MHC-recom- 
binant congenic mice as responder cells to generate polyclonal 
CTL  specific  for  K b or  D b.  By  stimulating  B10.A(18R) 
(KbA~EbD d) spleen cells with B6 cells, CTL specific for D b 
were obtained.  B10.A(4R)  (KkAkEnuUD  b) responder  spleen 
cells stimulated with B6 cells resulted in a population con- 
taining Kb-specific CTL. Fig. 3 shows that both populations 
lysed 3zm +,  H-2  b Con A  blast  target cells,  and with less 
efficiency, 32m-,  H-2  b target cells. In this and other experi- 
ments, B10.A(18R)  anti-B6 CTL achieved better and more 
reproducible lysis of 3zm-  target cells than did the B10.A(4R) 
anti-B6 CTL. These results suggest that anti-D b CTL are 
more efffcient than anti-K  b CTL at lysing 3zm-  target cells. 
To directly test  whether  the B10.A(18R)  anti-B6  CTL 
recognize D b on 32m-  target cells, antibody blocking ex- 
periments were performed. These experiments employed the 
mAb B22-249.1,  which recognizes  the cd  domain of D b. 
Binding of B22-249.1  mAb has been used as evidence that 
the cd domain of D b is in a properly folded conformation 
(1,  3,  10).  To minimize any sources of soluble 32m in the 
experiment,  the  target  cells  were  generated by culture in 
AIM-V medium, the assay was performed in AIM-V medium, 
and purified B22-249.1  IgG was employed. Nonsaturating 
effector/target ratios were used, based on a preliminary titra- 
tion experiment (Fig. 4 A). As shown in Fig. 4 B, B22-249.1 
IgG,  in  a  dose-dependent  manner,  inhibited lysis of both 
32m +  and/32m-  target  cells  by the  B10.A(18R)  anti-B6 
CTL. The antibody had no effect on lysis of H-2 k targets 
by B10.A(18R) anti-B10.BR CTL, demonstrating the spec- 
ificity of the effect. These results demonstrate directly that 
allospecific CTL can recognize D b molecule on 32m-  cells. 
The results further suggest that the D b molecules recognized 
are in a folded conformation detected by the B22-249.1 mAb. 
Although the previous experiments were performed under 
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Figure 4.  Inhibition of D b region-specific CTL by Db-specific mAb. 
In A, Db-specific CTL were titrated  on H-2  b/~zrn + targets (I) or H-2  b 
Bzm- targets (['3); and control H-2k-specific CTL were titrated  on H-2  ~ 
targets (A). In B, purified anti-Db antibodies (B22-249.1 mAb) were titrated 
into each CTbtarget reaction  at a constant  E/T ratio of 17:1. 
conditions minimizing sources of soluble B2m, it remained 
possible that B2m from the CTL themselves was transferred 
to the target cells during the cytolysis assay. To address this 
possibility,  we sought to employ a population of CTL that 
were Bum-. B2m- mice are deficient in CD8 + CTL. How- 
ever, differentiation of B2m- hematopoietic stem cells in ir- 
radiated Bum + mice leads to the efficient differentiation of 
CD8 +  CTL  precursors  under  the  influence of the  host 
thymus (Bix and Raulet, manuscript submitted for publica- 
tion). Therefore, to generate B2m-, H-2  k CTL precursors, 
we produced radiation chimeras by inoculating irradiated 
B10.BR  mice with bone marrow cells  from H-2  k,  B2m- 
donors.  13  wk  later,  spleen  cells  from  the  reconstituted 
chimeras and control B10.BR mice were isolated and stimu- 
lated twice consecutively in MLC with B6 spleen cells to 
generate anti-H-2  b CTL.  To deplete the minor fraction of 
radioresistant hematopoietic cells of host  (class I +) origin 
often found in radiation chimeras, the chimeric CTL popu- 
lation was depleted of residual radioresistant B2m+,  H-2  k 
cells by treatment with anti-H-2  k mAb (16-1-2n) plus com- 
plement on the day of the cytolysis assay. As before, the cy- 
tolysis assay and target cell cultures were performed in AIM-V 
medium. Thus, essentially no B2m was present in this ex- 
periment. 
As shown in Fig.  5 B,  the B2m-,  anti-H-2 k CTL lysed 
Bzm-, H-2  b target cells. Comparing dose-response curves, 
the lysis of B2m-  versus  that of B2m + target cells by the 
B2m-  CTL  was  similar  to  that  mediated by  the  B2m + 
(B10.BR) CTL, although the latter population was some- 
what more potent (compare Fig. 5, A and B). The depletion 
of residual H-2  k+ cells from the chimeric CTL population 
made no difference in the dose-response curves.  Depletion 
of H-2  k cells  from the control B10.BR  CTL  population 
eliminated CTL activity, demonstrating the effectiveness of 
the antibody plus complement treatment. These results sug- 
gest that lysis of B2m- H-2  b target cells by aUospecific CTL 
does not depend upon B2m. 
The data in the previous experiments do not distinguish 
whether most anti-H-2  b CTL in the populations lyse B2m-, 
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Figure 5.  Lysis  of B2m- targets by B2m- CTL. Anti-H-2  b CTL were 
prepared  in  secondary  MLC  against  H-2  b (B6)  stimulator  cells. Re- 
sponding CTL were from normal BIO.BR mice (A), or from bone marrow 
chimeras of the type (H-2  k Bzm- "-* B10.BR)  (B). They were tested for 
lysis of the indicated target cells: H-2  b Burn* targets (m, @); H.2  b Bzm- 
targets  ([-I, O); and H-2  k B2m + targets  (A). Before the assay, the CTL 
were depleted of class I + cells (@, O), or not (I,  I-l, A), and washed 
into serum-free  (AIM-V) medium. 
H-2  b targets poorly, or alternatively, that only a subset of 
anti-H-2  b CTL  lyse B2m-  targets.  As  one means  of ad- 
dressing this question,  we generated CTL by stimulating 
B10.BR responder spleen cells twice consecutively with ei- 
ther 32m-  or B2m + H-2  b stimulator spleen cells in MLC. 
Although significant CTL activity was not induced after only 
one round of stimulation with Bzm- cells (4), significant ac- 
tivity was usually evident after two or more rounds of stim- 
ulation (Fig.  6). These effector cells lysed B2m + and B2m- 
H-2  b targets with nearly equal efficiency, but did not lyse 
B10.BR target cells (Fig.  6 B). As in previous experiments, 
the CTL raised against B2m +,  H-2  b stimulator cells lysed 
B2m + target cells much better than they lysed B2m- target 
cells. These data suggest that a subset of anti-H-2  b CTL lyse 
Bum + and Bum-  target cells with nearly equal efficiency. 
To examine the expression of serologically detected class 
I epitopes on the B2m-  cells, we stained lymph node cells 
with a conformation-dependent anti-class  I antibody (B22- 
249.1), and examined them by flow cytometry. To ensure that 
no Bum was present in the experiment, we employed puri- 
fied antibody preparations, harvested the cells in serum-free 
medium,  and  stained the cells  in medium that  contained 
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Figure 6.  Stimulation  with B2m- cells  enriches  CTL that react equally 
well with Bzm- and Bzrn  + target cells. CTL were raised by stimulating 
B10.BR spleen  cells with H-2  b B2m § (A) or H-2  b B2m- (B) spleen  cells. 
CTL from secondary  MLC were tested against H-2  b Bzrn  § (I), H'2  b 
B2m- (V1), or H-2  k B2m  § (B10.BR) (&) target cells. 
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Figure  7.  ~2m-  lymph  node 
cells and Bzm-  tumor cells show 
cell surface expression of properly 
conformed  class I  D b molecules. 
Lymph node cells (a, b, and e) from 
/Jzm + H-2  b (B6  ￿  129)F5 (a), or 
~zm- H-2  b (B6  x  129)FS (b), or 
control Bzm + H-2  k (B10.BE)  (e) 
and ~2m + tumor calls (R1E-Db/ 
~2m) (c), B2m- tumor cells (RIE- 
D b)  (d), were  stained  with  bio- 
tinylated anti-D  b mAb (B22.249.1) 
in the presence of 5% FCS (dashed 
line) or in B2m-free medium (solid 
line). (Dotted line) Control staining 
with  second  reagent  (APC- 
streptavidin)  only.  Data  are  pre- 
sented as call number  vs log fluores- 
cence intensity. 
B-galactosidase  as a source of protein, instead of serum. We 
compared the staining of B2m-  lymph node cells to the 
staining of the Bzm- R1E/D  b tumor cells. As shown in Fig. 
7, B2m- lymph node cells stained with B22-249.1 mAb, al- 
though the intensity of staining was about 1/20th that of 
B2m + cells. This level of staining is similar to that observed 
in the presence of serum, which provides a source of B2m. 
The specificity of the staining is shown by the failure of the 
antibody to significantly stain BIO.BR (H-2  ~ cells). 
To  our  surprise,  B2m-  RIE/D b  cells  also  stained 
specifically with B22-249.1 mAb. The absolute intensity of 
staining was similar to that of B2m- lymph node cells. By 
comparison, the B2m  + variant of these cells, R1E/Db/~2m, 
stained more intensely than B2m + lymph node cells. Con- 
sidering that the tumor cells are larger than lymph node cells, 
it appears  that the/32m-  tumor cells may express a lower 
density of D b on their surface than the ~2m-  lymph node 
cells. 
Discussion 
Our results suggest that the D b molecule can assume a 
functional conformation in the absence of ~2m. This con- 
clusion is based on the findings that/3zm- cells were stained 
by the conformation-dependent B22-249.1  mAb in serum- 
free medium, and were lysed by allospecific ~2m-  CTL in 
serum-free medium. Furthermore, the Db-specific lysis of 
~2m-  cells  could  be  blocked  with  the  conformation- 
dependent B22-249.1  mAb. 
Our  results  with  the  R1E/D b cell  line contrast  with 
previous results suggesting that this cell line fails to present 
properly conformed H  chain at  the cell  surface  (1). The 
different results are not due to the use of different reagents, 
because the earlier studies, like ours, employed the B22-249.1 
mAb. It is likely that previous studies with R1E/D  b were 
not sufficiently sensitive to detect correctly conformed D b 
on the cells, since we find that successful detection requires 
a  highly  sensitive  staining  protocol  Although  R1E/D b 
stains  relatively  weakly  compared  with  the  staining  of 
K1E/Db/~2m, the results indicate that the expression of low 
levels of conformed D b H chains is a property of both nor- 
mal and transformed B2m-  cells. 
We further find that a subset of allospecific CTL, generated 
by multiple stimulations with ~zm-  cells, lyse ~2m-  and 
B2m + cells equally well. This observation, taken together 
with other findings, is most simply explained by assuming 
that these effectors recognize a set of properly conformed H 
chains, free of B2m, that are roughly equally represented on 
B2m + and/32m- cells. Whether these free H chains are as- 
sociated with peptides is not known. Evidence for CTL rec- 
ognition of peptide-free,  B2m-containing class I molecules 
has been reported (11). However,  it seems unlikely that H 
chains free of both peptides and B2m would maintain a func- 
tional conformation at the cell surface. 
We favor an alternative possibility,  that is suggested by 
recent findings that in the absence of/~2m, free D b H chains 
incubated with physiologically relevant,  nonamer peptides 
assume a conformation reactive with B22-249.1  mAb (3). 
High (micromolar) concentrations of peptide were required 
to observe this effect. Nonetheless, it is possible that some 
cellular  peptides bind to free D b H  chains in ~2m-  cells 
tightly enough to stabilize the properly folded conformation 
for transport to the cell surface. Such complexes might be 
expected to have a short half-life in the absence of B2m. Al- 
ternatively,  a subset of peptides may bind free H chains very 
tightly, resulting in stable complexes at the cell surface. 
A great deal of recent effort has been devoted to attempts 
to understand the assembly of class I H  chains with anti- 
genic peptides, and ~2m in vivo (3,  11-14). An important 
question is whether peptides associate with H  chain before 
or  after  B2m,  and  the  relative  contribution  of peptide 
binding and ~2m binding to the stability of the trimolecular 
complex. Our results raise the possibility that, at least in some 
instances, peptides may bind H chains in the absence of ~2m 
with sufficient affinity to establish a functionally conformed 
molecule on the cell surface. 
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